Pattern Of Endoscopic Findings In Patients Underwent Upper Endoscopy In Sohag University Hospital

Not Applicable

Completed

• Conditions: All Patients With Upper GIT Symptoms and Underwent Upper Endoscopy

• Registration Number: NCT05820061
• Lead Sponsor: Sohag University

Brief Summary

Diseases associated with upper gastrointestinal tract (UGIT) are common and associated with significant morbidity and mortality globally. Peptic ulcer disease, gastroesophageal reflux disease and cancers affect millions of people worldwide.

Upper endoscopy used for various diagnostic and therapeutic utic indications.

Detailed Description

Upper GI symptoms are common complaints among the general population and the underlying diseases associated with them carrey significant morbidit.To the best of our knowledge , there is few data about the prevalence rate of various endoscopic findings among Egyptian ptients with UGI symptoms.

Upper gastrointestinal endoscopy (UGIE) is a valuable tool in the diagnosis and management of diseases affecting the esophagus, stomach and upper parts of the duodenum . In addition to direct inspection of the mucosa, endoscopies can be used for therapeutic interventions. Standard diagnostic indications for UGIE include upper gastrointestinal bleeding, evaluation of persistent epigastric pain despite an appropriate trial of therapy, persistent vomiting, dysphagia, anemia, symptoms or signs suggesting structural disease (e.g., anorexia, weight loss,),new onset dyspepsia in a patient older than 50 years of age, heartburn, oesophageal reflux symptoms that persist or recur despite appropriate therapy, surveillance of malignancy, and screening for oesophageal varices in cirrhotic patients. Therapeutic indications include Esophageal variceal ligation, upper GI bleeding control, foreign body removal, dilation or stenting of strictures, placement of feeding tubes, management of achalasia and endoscopic mucosal resection (EMR).

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2020-01-01
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31
• Status Verified: 2023-03
• Study First Submitted: 2023-03-27
• Study First Submitted QC: 2023-04-06
• Last Update Submitted: 2023-04-06
• Study First Posted: 2023-04-19
• Last Update Posted: 2023-04-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

all patients underwent upper endoscopy for various indication at endoscopy unit of Tropical Medicine and Gastroenterology Department, Sohag University Hospital during the specified period of the study

Read More

Exclusion Criteria

• Absolute Contraindications

  • Perforated bowel.
  • Peritonitis.
  • Toxic megacolon in an unstable patient. Relative Contraindications
  • Severe neutropenia.
  • Coagulopathy.
  • Severe thrombocytopenia or impaired platelet function.• Increased risk of perforation including connective tissue disorders, recent bowel surgery or bowel obstruction.
  • Aneurysm of the abdominal and iliac aorta

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
spectrum of distribution of endoscopic findings	2 years	To assess endoscopic findings in patients presented with upper gastrointestinal symptoms

Trial Locations

Locations (1)

Sohag University Hospital; 🇪🇬 Sohag, Egypt